Cyanotech Corporation (CYAN) Receiving Somewhat Positive News Coverage, Report Shows
News stories about Cyanotech Corporation (NASDAQ:CYAN) have been trending somewhat positive on Monday, according to Accern. The research group identifies negative and positive press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cyanotech Corporation earned a news impact score of 0.12 on Accern’s scale. Accern also gave news coverage about the biotechnology company an impact score of 46.6674234500781 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:
- Global Canthaxanthin Market 2017- DSM, Cyanotech Corporation, Chengdu Biopurify , Kemin Industries, BASF – DailyHover (dailyhover.com)
- Algal Protein Market Value Share, Supply Demand 2017-2027 (industrytoday.co.uk)
- Global Microalgae Market Research Report 2017: DIC Corporation, Cyanotech Corporation, Algaetech Group (sbwire.com)
- New Concepts in Global Microalgae Market 2017-2022 (reports.pr-inside.com)
A number of research analysts have recently commented on the stock. ValuEngine raised shares of Cyanotech Corporation from a “sell” rating to a “hold” rating in a research report on Monday, August 14th. TheStreet raised shares of Cyanotech Corporation from a “d” rating to a “c-” rating in a report on Monday, August 28th.
Shares of Cyanotech Corporation (NASDAQ:CYAN) opened at 4.0594 on Monday. The company’s 50-day moving average is $4.47 and its 200 day moving average is $3.88. The stock’s market cap is $23.08 million. Cyanotech Corporation has a 1-year low of $3.25 and a 1-year high of $5.35.
Cyanotech Corporation (NASDAQ:CYAN) last issued its quarterly earnings results on Thursday, August 10th. The biotechnology company reported $0.09 earnings per share for the quarter. The firm had revenue of $8.81 million during the quarter. Cyanotech Corporation had a negative net margin of 0.07% and a negative return on equity of 0.14%. Equities research analysts anticipate that Cyanotech Corporation will post ($0.01) EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Cyanotech Corporation (CYAN) Receiving Somewhat Positive News Coverage, Report Shows” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/02/cyanotech-corporation-cyan-receiving-somewhat-positive-news-coverage-report-shows.html.
About Cyanotech Corporation
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Stock Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related stocks with our FREE daily email newsletter.